Details
| Stereochemistry | MIXED |
| Molecular Formula | C20H27N3O6 |
| Molecular Weight | 405.4449 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCCOCC(CN1C(=O)NC(=O)C(CC)(C1=O)C2=CC=CC=C2)OC(N)=O
InChI
InChIKey=QHZQILHUJDRDAI-UHFFFAOYSA-N
InChI=1S/C20H27N3O6/c1-3-5-11-28-13-15(29-18(21)26)12-23-17(25)20(4-2,16(24)22-19(23)27)14-9-7-6-8-10-14/h6-10,15H,3-5,11-13H2,1-2H3,(H2,21,26)(H,22,24,27)
| Molecular Formula | C20H27N3O6 |
| Molecular Weight | 405.4449 |
| Charge | 0 |
| Count |
|
| Stereochemistry | MIXED |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Febarbamate is a derivative of barbituric acid and carbamate, used for the treatment of generalized anxiety and alcohol withdrawal syndrome. The drug was marketed in Europe in the 1980s as a single agent or in combination with difebarbamate and phenobarbital, but it was later withdrawn from the market because of the potential risk of liver damage.
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:29:21 GMT 2025
by
admin
on
Mon Mar 31 18:29:21 GMT 2025
|
| Record UNII |
5Z48ONN38P
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-VATC |
QM03BA05
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
||
|
WHO-ATC |
M03BA05
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
||
|
NCI_THESAURUS |
C264
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
1135
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
C65626
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
13246-02-1
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
100000081786
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
24807
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | RxNorm | ||
|
5Z48ONN38P
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
1243
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
FEBARBAMATE
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
236-226-3
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
m1153
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | Merck Index | ||
|
DTXSID40864380
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
C003087
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104283
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
25803
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
SUB07519MIG
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY | |||
|
DB13303
Created by
admin on Mon Mar 31 18:29:21 GMT 2025 , Edited by admin on Mon Mar 31 18:29:21 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |